Evidence map›Paper›PMID 32064511›Full record

ArticleNucleic acids research2020

Synthetic CRISPR/Cas9 reagents facilitate genome editing and homology directed repair.

Sara E DiNapoli, Raul Martinez-McFaline, Caitlin K Gribbin, Paul J Wrighton, Courtney A Balgobin, Isabel Nelson, Abigail Leonard, Carolyn R Maskin, Arkadi Shwartz, Eleanor D Quenzer and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Sara E DiNapoliDepartment of Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA.
Raul Martinez-McFalineDepartment of Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA.
Caitlin K GribbinDepartment of Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA.
Paul J WrightonDepartment of Medicine, Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Courtney A BalgobinDepartment of Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA.
Isabel NelsonDepartment of Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA.
Abigail LeonardDepartment of Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA.
Carolyn R MaskinDepartment of Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA.
Arkadi ShwartzDepartment of Medicine, Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Eleanor D QuenzerDepartment of Medicine, Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Darya MailhiotDepartment of Surgery, Animal Resources Center, University of Chicago, Chicago, IL, USA.
Clara KaoDepartment of Pediatrics, University of Chicago, Chicago, IL, USA.
Sean C McConnellDepartment of Pediatrics, University of Chicago, Chicago, IL, USA.
Jill L O de JongDepartment of Pediatrics, University of Chicago, Chicago, IL, USA.
Wolfram GoesslingDepartment of Medicine, Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Yariv HouvrasDepartment of Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA.
NewYork–Presbyterian Hospital · USBrigham and Women's Hospital · USUniversity of Chicago · US

Funding

Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
A Community Zebrafish Resource for Modeling GWAS BiologyR24OD017870 · OD · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM, MACRAE, CALUM A. · 2014 to 2021
$6.3M
J. NRSA Training CoreTL1TR002386 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Genevieve Giny Fouda Amou ou · 2017 to 2026
$5.8M
Estrogen Regulation of Hepatic GrowthR01DK090311 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM · 2011 to 2020
$4.9M
Metabolic Regulation of Liver GrowthR01DK105198 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM · 2016 to 2020
$2.7M
Clinical and Translational Science CenterTL1TR000459 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$451k
Understanding the mechanism of H3K9 HMT mediated suppression of melanomaF31CA213997 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MARTINEZ-MCFALINE, RAUL J. · 2016 to 2019
$189k
The role of mechanical signaling in alcoholic liver disease and hepatocellular carcinomaF32AA025271 · NIAAA · BRIGHAM AND WOMEN'S HOSPITAL · PI WRIGHTON, PAUL J. · 2016 to 2018
$174k
Understanding the role of Polycomb Repressive Complex 2 in melanomaF31CA192813 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI DINAPOLI, SARA · 2015 to 2017
$131k
NCATS NIH HHS TL1 TR000459NCATS NIH HHS TL1 TR002386NCATS NIH HHS UL1 TR002384NCI NIH HHS F31 CA192813NCI NIH HHS F31 CA213997NIAAA NIH HHS F32 AA025271NIDDK NIH HHS R01 DK090311NIDDK NIH HHS R01 DK105198NIGMS NIH HHS T32 GM007739NIH HHS R24 OD017870
6 · The paper itself

Abstract

CRISPR/Cas9 has become a powerful tool for genome editing in zebrafish that permits the rapid generation of loss of function mutations and the knock-in of specific alleles using DNA templates and homology directed repair (HDR). We examined the efficiency of synthetic, chemically modified gRNAs and demonstrate induction of indels and large genomic deletions in combination with recombinant Cas9 protein. We developed an in vivo genetic assay to measure HDR efficiency and we utilized this assay to test the effect of altering template design on HDR. Utilizing synthetic gRNAs and linear dsDNA templates, we successfully performed knock-in of fluorophores at multiple genomic loci and demonstrate transmission through the germline at high efficiency. We demonstrate that synthetic HDR templates can be used to knock-in bacterial nitroreductase (ntr) to facilitate lineage ablation of specific cell types. Collectively, our data demonstrate the utility of combining synthetic gRNAs and dsDNA templates to perform homology directed repair and genome editing in vivo.

Indexed as

CRISPR-Associated Protein 9CRISPR-Cas SystemsGene EditingRecombinational DNA RepairAnimalsFluorescent DyesGreen Fluorescent ProteinsINDEL MutationIndicators and ReagentsMelanocytesNitroreductasesRNATemplates, GeneticZebrafishCRISPR-Associated Protein 9enhanced green fluorescent proteinFluorescent DyesGreen Fluorescent ProteinsIndicators and ReagentsNitroreductasesRNA

Identifiers

PMID32064511
PMCPMC7144937
OpenAlexW3008149374

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.